Direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patients.
Several studies have suggested that the autoantibodies (autoAbs) against muscle acetylcholine receptor (AChR) of myasthenia gravis (MG) patients are the main pathogenic factor in MG; however, this belief has not yet been confirmed with direct observations. Although animals immunized with AChR or inj...
Main Authors: | Gregory Kordas, George Lagoumintzis, Sotirios Sideris, Konstantinos Poulas, Socrates J Tzartos |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4178151?pdf=render |
Similar Items
-
Correction: direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patients.
by: PLOS ONE Staff
Published: (2015-01-01) -
Correction: Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients.
by: PLOS ONE Staff
Published: (2015-01-01) -
Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK.
by: Vuslat Yilmaz, et al.
Published: (2015-01-01) -
Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management
by: Konstantinos Lazaridis, et al.
Published: (2020-11-01) -
Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics
by: Konstantinos Lazaridis, et al.
Published: (2020-02-01)